National Exhaustive Cohort of Hereditary Stomatocytoses and Other Channelopathies Affecting the Red Blood Cell

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAssistance Publique - Hôpitaux de Paris

About this trial

Hereditary stomatocytosis is a heterogeneous group of rare constitutional diseases of dominant transmission in the vast majority of cases. The data concerning their clinical and biological presentation, and their evolution are few, and come from about thirty clinical cases. The constitution of an exhaustive French cohort of hereditary stomatocytosis will improve the establishment of the diagnosis and the management of patients

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Any patient with a diagnosis of stomatocytosis without age limit

Patient affiliated or beneficiary of french Social Security

No objection from the patient or legal representative

Disqualifiers

Diagnosis of stomatocytosis excluded by ektacytometry and / or genetics

Patient under guardianship, with curators or legal protection

Trial population

all patients for whom the diagnosis of hereditary stomatocytosis has been made or confirmed by ektacytometry

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Obtain a description of the clinical and laboratory data of patients at the time of diagnosis of stomatocytosis

Descriptive analysis of clinical and biological data for the diagnosis of stomatocytosis

Time frame
Baseline

Secondary outcomes

1

Determine the proportion of recurrent genetic mutations and private mutations within our cohort

Number of recurrent genetic mutations and private mutations within our cohort

Time frame
Baseline
2

Establish phenotypes-genotypes relationships

Specify the phenotypic presentation of each mutation and isolate any correlations genotype-phenotype

Time frame
through study completion, an average of 15years
3

Describe the appearance of complications

Rate of occurrence of complications over time

Time frame
through study completion, an average of 15years
4

Describe possible new phenotypic presentations of hereditary stomatocytosis

Description of the phenotypic presentations of hereditary stomatocytosis

Time frame
through study completion, an average of 15years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.